Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.
Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Lilly Clinical Trial

7  Enrolling
20  Total Trials
Conditions: Breast Cancer
Trial Name
EMBER-4
Drugs: Anastrozole, Exemestane, Imlunestrant, Letrozole, Tamoxifen
Age
≥18 years
Phase
III
Conditions: Lung Cancer, Advanced Solid Tumors
Drugs: LY3537982, Abemaciclib, Pembrolizumab, LY3295668, Cetuximab
Age
≥18 years
Phase
I
Conditions: Solid tumors
Drugs: LY4101174
Age
≥18 years
Phase
I
Conditions: Lung Cancer, Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer, Uterine Cancer
Drugs: LY4170156
Age
≥18 years
Phase
I
Conditions: Bladder Cancer, Advanced Solid Tumors
Drugs: LOX-24350 / LOXO-435, Pembrolizumab
Age
≥18 years
Phase
I
Conditions: Breast Cancer, Advanced Solid Tumors
Trial Name
PIKASSO-01
Drugs: LOXO-783
Age
≥18 years
Phase
I
Conditions: Breast Cancer
Trial Name
EMBER-3
Drugs: LY3484356, Exemestane, Fulvestrant, Imlunestrant, Abemaciclib
Age
≥18 years
Phase
III

Lilly Trial Alerts

Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
13 
Completed Enrollment
20  Total Trials
Conditions: Advanced Solid Tumor
Drugs: LY3410738
Age
≥18 years
Phase
I
Conditions: Advanced Solid Tumor
Trial Name
PACT
Drugs: Ramucirumab, Abemaciclib, Merestinib, LY3300054
Age
≥18 years
Phase
I
Conditions: Advanced Solid Tumor
Drugs: LY3200882
Age
≥18 years
Phase
I
Conditions: Breast Cancer, Endometrial Cancer
Trial Name
EMBER
Drugs: LY3484356, Abemaciclib
Age
≥18 years
Phase
I
Conditions: Breast Cancer
Trial Name
monarchE
Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Age
≥18 years
Phase
III
Conditions: Breast Cancer
Trial Name
postMONARCH
Drugs: Abemaciclib, Fulvestrant
Age
≥18 years
Phase
III
Conditions: Breast Cancer
Trial Name
eMonarcHER
Drugs: Abemaciclib Plus Hormone Therapy
Age
≥18 years
Phase
III
Conditions: Advanced Solid Tumors
Drugs: Abemaciclib, Irinotecan, Temozolomide, Dinutuximab and GM-CSF
Age
≤21 years
Phase
II
Conditions: Breast Cancer
Trial Name
Next MONARCH 1
Drugs: Abemaciclib, Tamoxifen, Prophylactic Loperamide
Age
≥18 years
Phase
II
Conditions: Breast Cancer
Trial Name
MONARCH plus
Drugs: Abemaciclib, Anastrozole, Letrozole, Fulvestrant
Age
≥18 years
Phase
III
Conditions: Lung Cancer, Thyroid Cancer and other Solid Tumors
Trial Name
JUVE-BASIS
Drugs: LOXO-260
Age
≥12 years
Phase
I
Conditions: Breast Cancer
Drugs: LY2835219, Letrozole, Anastrozole, Tamoxifen, Exemestane
Age
≥18 years
Phase
I
Conditions: Breast Cancer, Non-Small Cell Lung Cancer
Drugs: Abemaciclib, Pembrolizumab
Age
≥18 years
Phase
I